Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 5,015,148
  • Shares Outstanding, K 43,440
  • Annual Sales, $ 1,599 M
  • Annual Income, $ 713,700 K
  • 36-Month Beta 1.52
  • Price/Sales 3.14
  • Price/Cash Flow 6.57
  • Price/Book 2.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.54 +0.05%
on 09/22/17
136.17 -15.84%
on 09/06/17
-16.68 (-12.71%)
since 08/22/17
3-Month
114.54 +0.05%
on 09/22/17
139.10 -17.61%
on 08/04/17
-17.10 (-12.98%)
since 06/22/17
52-Week
110.90 +3.34%
on 10/21/16
169.89 -32.54%
on 02/21/17
-12.41 (-9.77%)
since 09/22/16

Most Recent Stories

More News
Is United Therapeutics a Great Stock for Value Investors?

Let's see if United Therapeutics Corporation (UTHR) stock is a good choice for value-oriented investors right now from multiple angles.

UTHR : 114.60 (-0.74%)
Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds

Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is featured in Forbes magazine's special centennial issue, released today, as one of The World's...

UTHR : 114.60 (-0.74%)
Daily Technical Summary Reports on Healthcare Stocks -- Shire, Aerie Pharma, Heron Therapeutics, and United Therapeutics

If you want a Stock Review on SHPG, AERI, HRTX, or UTHR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has investors'...

AERI : 50.95 (-0.97%)
SHPG : 155.09 (-0.17%)
UTHR : 114.60 (-0.74%)
HRTX : 15.20 (+0.33%)
United Therapeutics Announces FREEDOM-EV Study Of Orenitram® To Continue As Planned Following Interim Analysis

United Therapeutics Corporation (NASDAQ: UTHR) today announced that the independent data monitoring committee (DMC) for the FREEDOM-EV study of Orenitram (treprostinil) extended-release tablets had completed...

UTHR : 114.60 (-0.74%)
J&J (JNJ) PAH Drug's U.S. Label Expanded for Pediatric Use

Johnson & Johnson (JNJ), a healthcare bellwether, announced that the FDA has approved a label expansion for its oral pulmonary arterial hypertension (PAH) medicine, Tracleer.

JNJ : 131.39 (-0.27%)
ARNA : 25.09 (-0.08%)
PFE : 35.96 (-0.03%)
UTHR : 114.60 (-0.74%)
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform

---Contributions of Capital, More Than 200+ Issued and Pending Patents, Pre-Clinical and Clinical Assets and Commercial Products Obtained from Companies Including Celgene Corporation, Sorrento Therapeutics...

SRNE : 1.80 (unch)
CELGZ : 1.55 (+23.51%)
UTHR : 114.60 (-0.74%)
Sorrento Contributes To The Formation Of Celularity, Inc. For Breakthrough Placental Therapeutic Platform In Consortium With Leading Pharmaceutical Companies

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced that the transactions contemplated by the Contribution Agreement it entered with Celularity, Inc. ("Celularity") has closed. Sorrento previously...

SRNE : 1.80 (unch)
CELGZ : 1.55 (+23.51%)
UTHR : 114.60 (-0.74%)
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform

New Biotechnology Company Accelerates the Delivery of Transformative Innovations in Treatments of Cancer, Inflammatory & Degenerative Diseases, and Functional Regeneration

SRNE : 1.80 (unch)
CRT : 14.76 (+1.10%)
CELGZ : 1.55 (+23.51%)
UTHR : 114.60 (-0.74%)
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform

---New Biotechnology Company Accelerates the Delivery of Transformative Innovations in Treatments of Cancer, Inflammatory & Degenerative Diseases, and Functional Regeneration

SRNE : 1.80 (unch)
CELGZ : 1.55 (+23.51%)
UTHR : 114.60 (-0.74%)
SmarTrend Watching for Potential Pullback in Shares of United Therapeut After 3.01% Gain

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $129.53 to a high of $134.10. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

UTHR : 114.60 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.

See More

Support & Resistance

2nd Resistance Point 116.02
1st Resistance Point 115.31
Last Price 114.60
1st Support Level 114.21
2nd Support Level 113.83

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.